In recent years cell therapies have evolved and matured, moving from academia to industry.
Scale up of a process is the natural path of any product evolutionary development and …

In recent years cell therapies have evolved and matured, moving from academia to industry.
Scale up of a process is the natural path of any product evolutionary development and …

A study was undertaken that validates the business models of biotechnology companies that
compete in the pharmaceutical marketplace. Strategic alliances, largely with established …

This article provides new insights into the different strategy paths or business models
currently being implemented by Canadian biopharma companies. Through a case-study …

The processes of discovery, testing and distribution of new medicines have undergone
radical change in recent decades, from a focus on small molecule drugs to biomedicine and …

The current trend of business model research shows an increased endeavour of
conceptualizing business frameworks for circular economy (CE). While previous …

Most books on the biotechnology industry focus on scientific and technological challenges,
ignoring the entrepreneurial and managerial complexities faced bio-entrepreneurs. The …

The objective of this study was to develop recommendations for business model design,
similar to those developed by Amit, R. and Zott, C.(2001)'Value creation in e-business' …

Critical success factors and performance indicators provide the biotechnology industry with
a foundation on which to grow and manage risks. In a recent survey of 247 biotechnology …

Using the framework of the business model developed in Rasmussen (2007b) this paper
presents an outline of the traditional pharmaceutical company business model, and how it …